Page 9 - Flipbook

ERSPC (European Randomized Study of Screening

for Prostate Cancer)

• 162 243 men aged 55 to 69 years

• PSA screening once q1-4 years or an unscreened control group

• Median f/u 11 years

• The cumulative incidence of PCa was 8.2% in the screened group

vs 4.8%

• PCa death was reduced by 21% and 29% after adjustment for

noncompliance

• 9 years (NNS 1410, NND 48)